Aldeyra Therapeutics

ALDXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$36.709 M

$0.61 -6.01%

Close of 6 Nov 2026

As of 6 Nov 2026, Aldeyra Therapeutics (ALDX) has a market capitalization of $36.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$33.8M

Loss-making

Shares outstanding

60,356,541

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#353Grace TherapeuticsGRCE$37.7M
#354Impact BiomedicalIBO$37.6M
#355Aldeyra TherapeuticsALDX$36.7M
#356VeruVERU$35.0M
#357GridAI TechnologiesGRDX$33.9M

What if Aldeyra Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$468,068.11

Per share 769,216× higher

Bitcoin $1.53T

$25,326.35

Per share 41,621× higher

Apple $5.02T

$83,144.04

Per share 136,638× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Aldeyra Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.